SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14F1 - Statement regarding change in majority of directors [Rule 14f-1]:
SEC Accession No. 0001213900-21-011933
Filing Date
2021-02-26
Accepted
2021-02-26 08:58:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14F-1 ea136370-sc14f1_wizepharama.htm SC 14F1 164912
  Complete submission text file 0001213900-21-011933.txt   166802
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filed by) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14F1
SIC: 2834 Pharmaceutical Preparations

Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Subject) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14F1 | Act: 34 | File No.: 005-82946 | Film No.: 21684021
SIC: 2834 Pharmaceutical Preparations